Dr. Imteyaz Qamar is working as an assistant professor at School of biotechnology, Gautam Buddha University, Greater Noida, India. His area on interest is Stress biology, and Cancer Genetics He earned his Ph.D. in Molecular Endocrinology from Chonnam National University, South Korea with an emphasis on gene regulation and physiological function of an androgen receptor corepressor-19kD using mice model. He has written various manuscripts, grants, progress reports, pre-IND protocols, animal protocols and published in well reputed international journals. He has also received various awards such as Brain Korea-21 Best Research presenter award 2007, Bharath Vikas award 2016, Young Scientist Award 2017 & 2019, STE meritorious award 2019 etc. He serves as a member of editorial boards of various peer reviewed journals. He is also a member of the endocrinology society, United States of America (USA). Dr. Pawan Kumar Maurya is a biochemist and Professor in the Department of Biochemistry at the Central University of Haryana, where he also serves as Dean of Academic Affairs. He earned his MSc and PhD in Biochemistry from the University of Allahabad. His research spans oxidative stress, aging, nanomedicine, and clinical biochemistry. He has completed postdoctoral training at several institutions in Asia and Brazil. Dr. Maurya has been honored with national and international awards for his work. He is active in professional societies including the Association of Gerontology India, the Society of Neurochemistry India, and Indian Biochemists’ and Microbiologists’ associations. His scholarly output includes books, book chapters, and numerous research articles. He contributes to technical and organizing committees for national and international conferences. A dedicated educator, he specializes in biochemical diagnostics, nanomedicine, and clinical biochemistry, with a track record of editorial work with major publishers.

"...a multi-authored reference text on cardiovascular toxicity and therapeutic modalities targeting cardio-oncology… [by] national and international thought leaders in their respective fields…. This book gives a comprehensive, up-to-date overview of the basics of the cardiovascular system, cardiovascular diseases in cancer survivors, recent trends in cancer immunotherapy, cardiotoxic effects of various chemo- radiotherapeutic modalities, and biomarkers involved in such cardiotoxicities… [with] an overview of topics such as hemopoietic stem cell transplant, stroke risk in cancer patients, cardiovascular imaging, and cardiac rehabilitation…. This book is a valuable resource… The authors have done the utmost justice in providing high-quality content." --©Doody’s Review Service, 2023, Aditya Nitin Thakkar, MD (East Tennessee State University Quillen College of Medicine)

• 1. Preface2. Overview of changes in the Cardiovascular system3. Cardiovascular Disease in cancer survivors: Risk and management4. Recent trends in Cancer Immunotherapy: Pathways and inhibitors5. Stroke risk assessment and Atrial fibrillation in cancer patients6. Biochemistry of Biomarkers in Cardiotoxicity induced by chemotherapeutic drugs7. Cardio-toxic effects of Tyrosine kinase inhibitors directed against VEGFR8. Critical insights into Cardiotoxicity of Anthracyclines9. Noninvasive Cardiovascular imaging techniques10. Radiotherapy induced( RIDH) Cardiovascular risk11. Cardiovascular complication from cancer therapy12. Novel Anticancer drugs related to Cardiotoxicity13. Principles of cardiovascular rehabilitation14. Hematopoietic stem cell transplantation

Dr. Imteyaz Qamar is working as an assistant professor at School of biotechnology, Gautam Buddha University, Greater Noida, India. His area on interest is Stress biology, and Cancer Genetics He earned his Ph.D. in Molecular Endocrinology from Chonnam National University, South Korea with an emphasis on gene regulation and physiological function of an androgen receptor corepressor-19kD using mice model. He has written various manuscripts, grants, progress reports, pre-IND protocols, animal protocols and published in well reputed international journals. He has also received various awards such as Brain Korea-21 Best Research presenter award 2007, Bharath Vikas award 2016, Young Scientist Award 2017 & 2019, STE meritorious award 2019 etc. He serves as a member of editorial boards of various peer reviewed journals. He is also a member of the endocrinology society, United States of America (USA). Dr. Pawan Kumar Maurya is a biochemist and Professor in the Department of Biochemistry at the Central University of Haryana, where he also serves as Dean of Academic Affairs. He earned his MSc and PhD in Biochemistry from the University of Allahabad. His research spans oxidative stress, aging, nanomedicine, and clinical biochemistry. He has completed postdoctoral training at several institutions in Asia and Brazil. Dr. Maurya has been honored with national and international awards for his work. He is active in professional societies including the Association of Gerontology India, the Society of Neurochemistry India, and Indian Biochemists’ and Microbiologists’ associations. His scholarly output includes books, book chapters, and numerous research articles. He contributes to technical and organizing committees for national and international conferences. A dedicated educator, he specializes in biochemical diagnostics, nanomedicine, and clinical biochemistry, with a track record of editorial work with major publishers.

"...a multi-authored reference text on cardiovascular toxicity and therapeutic modalities targeting cardio-oncology… [by] national and international thought leaders in their respective fields…. This book gives a comprehensive, up-to-date overview of the basics of the cardiovascular system, cardiovascular diseases in cancer survivors, recent trends in cancer immunotherapy, cardiotoxic effects of various chemo- radiotherapeutic modalities, and biomarkers involved in such cardiotoxicities… [with] an overview of topics such as hemopoietic stem cell transplant, stroke risk in cancer patients, cardiovascular imaging, and cardiac rehabilitation…. This book is a valuable resource… The authors have done the utmost justice in providing high-quality content." --©Doody’s Review Service, 2023, Aditya Nitin Thakkar, MD (East Tennessee State University Quillen College of Medicine)

• 1. Preface2. Overview of changes in the Cardiovascular system3. Cardiovascular Disease in cancer survivors: Risk and management4. Recent trends in Cancer Immunotherapy: Pathways and inhibitors5. Stroke risk assessment and Atrial fibrillation in cancer patients6. Biochemistry of Biomarkers in Cardiotoxicity induced by chemotherapeutic drugs7. Cardio-toxic effects of Tyrosine kinase inhibitors directed against VEGFR8. Critical insights into Cardiotoxicity of Anthracyclines9. Noninvasive Cardiovascular imaging techniques10. Radiotherapy induced( RIDH) Cardiovascular risk11. Cardiovascular complication from cancer therapy12. Novel Anticancer drugs related to Cardiotoxicity13. Principles of cardiovascular rehabilitation14. Hematopoietic stem cell transplantation

Dr. Imteyaz Qamar is working as an assistant professor at School of biotechnology, Gautam Buddha University, Greater Noida, India. His area on interest is Stress biology, and Cancer Genetics He earned his Ph.D. in Molecular Endocrinology from Chonnam National University, South Korea with an emphasis on gene regulation and physiological function of an androgen receptor corepressor-19kD using mice model. He has written various manuscripts, grants, progress reports, pre-IND protocols, animal protocols and published in well reputed international journals. He has also received various awards such as Brain Korea-21 Best Research presenter award 2007, Bharath Vikas award 2016, Young Scientist Award 2017 & 2019, STE meritorious award 2019 etc. He serves as a member of editorial boards of various peer reviewed journals. He is also a member of the endocrinology society, United States of America (USA). Dr. Pawan Kumar Maurya is a biochemist and Professor in the Department of Biochemistry at the Central University of Haryana, where he also serves as Dean of Academic Affairs. He earned his MSc and PhD in Biochemistry from the University of Allahabad. His research spans oxidative stress, aging, nanomedicine, and clinical biochemistry. He has completed postdoctoral training at several institutions in Asia and Brazil. Dr. Maurya has been honored with national and international awards for his work. He is active in professional societies including the Association of Gerontology India, the Society of Neurochemistry India, and Indian Biochemists’ and Microbiologists’ associations. His scholarly output includes books, book chapters, and numerous research articles. He contributes to technical and organizing committees for national and international conferences. A dedicated educator, he specializes in biochemical diagnostics, nanomedicine, and clinical biochemistry, with a track record of editorial work with major publishers.

"...a multi-authored reference text on cardiovascular toxicity and therapeutic modalities targeting cardio-oncology… [by] national and international thought leaders in their respective fields…. This book gives a comprehensive, up-to-date overview of the basics of the cardiovascular system, cardiovascular diseases in cancer survivors, recent trends in cancer immunotherapy, cardiotoxic effects of various chemo- radiotherapeutic modalities, and biomarkers involved in such cardiotoxicities… [with] an overview of topics such as hemopoietic stem cell transplant, stroke risk in cancer patients, cardiovascular imaging, and cardiac rehabilitation…. This book is a valuable resource… The authors have done the utmost justice in providing high-quality content." --©Doody’s Review Service, 2023, Aditya Nitin Thakkar, MD (East Tennessee State University Quillen College of Medicine)

• 1. Preface2. Overview of changes in the Cardiovascular system3. Cardiovascular Disease in cancer survivors: Risk and management4. Recent trends in Cancer Immunotherapy: Pathways and inhibitors5. Stroke risk assessment and Atrial fibrillation in cancer patients6. Biochemistry of Biomarkers in Cardiotoxicity induced by chemotherapeutic drugs7. Cardio-toxic effects of Tyrosine kinase inhibitors directed against VEGFR8. Critical insights into Cardiotoxicity of Anthracyclines9. Noninvasive Cardiovascular imaging techniques10. Radiotherapy induced( RIDH) Cardiovascular risk11. Cardiovascular complication from cancer therapy12. Novel Anticancer drugs related to Cardiotoxicity13. Principles of cardiovascular rehabilitation14. Hematopoietic stem cell transplantation